INVO Bioscience Inc INVO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INVO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.72
- Day Range
- $0.72–0.84
- 52-Week Range
- $0.50–7.20
- Bid/Ask
- $0.78 / $0.82
- Market Cap
- $3.12 Mil
- Volume/Avg
- 56,861 / 122,753
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 30
- Website
- https://www.invobio.com
Valuation
|
Metric
|
INVO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.46 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
INVO
|
|---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.19 |
Interest Coverage | −6.92 |
Quick Ratio
INVO
Profitability
|
Metric
|
INVO
|
|---|---|
Return on Assets (Normalized) | −39.55% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −78.31% |
Return on Assets
INVO
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Ksklhzsc | Bgtdqwd | $183.1 Bil | |||
| Stryker Corp
SYK
| Tnqpwdssb | Nkc | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Vcdnvhm | Nrbmjm | $110.1 Bil | |||
| Medtronic PLC
MDT
| Djxwlbsdv | Kjznfq | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Dlhhwrwt | Yvgrql | $37.6 Bil | |||
| DexCom Inc
DXCM
| Dkqbvtnm | Jnsvd | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Tgnxpgsw | Wclrrr | $24.1 Bil | |||
| Steris PLC
STE
| Lfrfwqx | Yrqwwb | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Twnzhtqvh | Vrhm | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Jkckbnffl | Cfsjpmf | $16.6 Bil |